APA

Lewis R. A., McDermott M. P., Herrmann D. N., Hoke A., Clawson L. L., Siskind C., Feely S. M. E., Miller L. J., Barohn R. J., Smith P., Luebbe E., Wu X. & Shy M. E. (20131115). High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trial. : JAMA neurology.

Chicago

Lewis Richard A, McDermott Michael P, Herrmann David N, Hoke Ahmet, Clawson Lora L, Siskind Carly, Feely Shawna M E, Miller Lindsey J, Barohn Richard J, Smith Patricia, Luebbe Elizabeth, Wu Xingyao and Shy Michael E. 20131115. High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trial. : JAMA neurology.

Harvard

Lewis R. A., McDermott M. P., Herrmann D. N., Hoke A., Clawson L. L., Siskind C., Feely S. M. E., Miller L. J., Barohn R. J., Smith P., Luebbe E., Wu X. and Shy M. E. (20131115). High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trial. : JAMA neurology.

MLA

Lewis Richard A, McDermott Michael P, Herrmann David N, Hoke Ahmet, Clawson Lora L, Siskind Carly, Feely Shawna M E, Miller Lindsey J, Barohn Richard J, Smith Patricia, Luebbe Elizabeth, Wu Xingyao and Shy Michael E. High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trial. : JAMA neurology. 20131115.